Home > Healthcare > Medical Devices > Implantable Devices > Artificial Disc Market
Artificial Disc Market size crossed USD 1.6 billion in 2022 and is predicted to exhibit over 3% CAGR from 2023-2032. Growing demand for cervical-total disc replacement is projected to complement the market expansion.
Surging incidences of degenerative disc diseases across the world are expected to positively impact the dynamics. According to Medicare, the rate of prevalence of spine degeneration is more than 25% in the U.S., with a higher incidence rate in women as compared to men. The rising geriatric population represents a massive patient pool with unmet healthcare needs associated with back pain driven by musculoskeletal aging. For instance, according to the National Commission on Population, the elderly population in India is expected to account for 18% of the total population by 2036.
Report Attribute | Details |
---|---|
Base Year: | 2019 |
Artificial Disc Market Size in 2019: | USD 1.6 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 3.1% |
2032 Value Projection: | USD 2.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 125 |
Tables, Charts & Figures: | 181 |
Segments covered: | Type, Material, Indication, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The COVID-19 crisis introduced several challenges in the healthcare sector, including the artificial disc market. It led to a significant decline in the number of artificial disc replacement procedures performed owing to the increasing focus on the treatment of the infected patients. Several government authorities worldwide imposed stringent lockdowns along with trade restrictions, hampering the supply chain. Additionally, the growing concerns associated with the risk of virus transmission within hospital settings negatively influenced the patient willingness toward hospitalization. Furthermore, numerous healthcare facilities delayed non-emergency procedures due to the burgeoning hospitalization rate driven by the pandemic, limiting the requirement for artificial discs.
The rising costs of implants and the lack of reimbursement are among the key roadblocks hindering the artificial discs market growth. The increasing sophistication of technologies used in medical devices and implants adds to the cost of these products. For instance, a cervical total disc replacement (CTDR) implant costs between USD 9,000 to USD 12,000. However, advancements in CTDR devices for the treatment of cervical diseases and adequate training for surgeons for proper handling of the medical equipment will enhance the industry scope.
Artificial disc market valuation from cervical artificial discs segment is poised to surpass USD 1.5 billion by 2032. Cervical disc replacement procedures are extensively performed as an alternative to spinal fusion for faster recovery after replacement. The growing concerns associated with post-surgery risks of spinal fusion has accelerated the patient preference for cervical artificial disc replacement procedures. This type of disc replacement method offers less recovery time, better results than fusion, long-lasting results, and low risk of reoperation at the same/different cervical level. Additionally, the rising incidence rate of cervicogenic headaches caused by problems in the upper cervical spine will proliferate the demand for artificial discs.
Based on material, the metal-on-metal material segment accounted for more than 36% share of the artificial disc market in 2022. As compared to metal-on-biopolymer, metal-on-metal devices are relatively cheaper, and thus record significant preference. Metal-based implants made up of cobalt-based alloys, stainless steel, and titanium-based alloys are extensively used to manufacture diverse orthopedic implants. These implants are cost-effective, durable, and feature excellent mechanical properties. The ongoing developments and studies conducted for the development of degradable metal-based implants will also augment the artificial disc industry.
In terms of revenue, the artificial disc market share from degenerative spine diseases is poised to exceed USD 1.7 billion by 2032. The growing number of patients suffering from degenerative spine disease is expected to fuel the demand for artificial disc replacement procedures across the globe. The presence of degenerated discs in the lumbar spine increases the risk of chronic lower back pain, necessitating appropriate treatment. Low back pain (LBP) is a major contributor to the healthcare burden and has thus compelled several governments to introduce favorable policies.
Artificial disc market from ambulatory surgical centers segment is projected to exhibit over 2.5% CAGR from 2023-2032. The growing number of artificial disc replacement procedures performed in ambulatory surgical centers (ASCs) can be credited to the presence of favorable reimbursement scenario. Additionally, ASCs offer convenient and affordable healthcare along with access to state-of-the-art medical equipment and implants, thus attracting a large patient pool. Moreover, the advent of outpatient spine surgery and the growing preference for minimally invasive spine treatment will boost the demand for artificial discs across these settings.
North America artificial disc market is estimated to surpass USD 1.3 billion by 2032. North America is home to economies such as the U.S. and Canada with a robust healthcare infrastructure and a solid footprint of healthcare facilities. According to the American Hospital Association data, the U.S. has more than 6,000 registered hospitals. The surging geriatric population, the rapid integration of advanced medical technologies and the rising disposable income will augment industry expansion across North America. As per the U.S. Census Bureau, the number of individuals aged 65 years and above is anticipated to increase from 56 million in 2022 to more than 73 million in 2030 and further surpass 85 million by 2050, accounting for over 20% of the overall U.S. population.
Some of the leading companies in the artificial disc market include
These firms are focusing on the development of novel technologies and innovative products to improve their market identity. For instance, in September 2022, NuVasive, Inc. unveiled Reline Cervical fixation system designed for posterior cervical fusion.
Click here to Buy Section of this Report
By Type
By Material
By Indication
End-use
The above information is provided for the following regions and countries: